Abstract
Synchronous bilateral breast cancer and thymoma is rare, requiring vigilant surveillance and multidisciplinary management. This case highlights the importance of distinguishing multiple primary malignancies from metastases, emphasizing tailored multimodal therapy and long-term follow-up to address immune dysregulation and cancer predisposition.